Treg cells migrate in response to CSF supernatants obtained from patients with NM. CIs of Treg cells from a healthy donor toward CSF supernatants of patients with NM and control diseases as determined by transwell migration assays. Original input PBMCs and migrated cells were stained with CD4/CD25 mAbs and gated on CD4+ cells. CI was calculated by dividing percentages of Treg cells in CD4+ T cells of migrated cells by percentages of Treg cells in CD4+ T cells in original input PBMCs. Symbols indicate CI-Treg of individual patients. Means are indicated.